Mitochondrial dysfunction associated with TANGO2 deficiency
Paige Heiman, Al-Walid Mohsen, Anuradha Karunanidhi, Claudette St Croix, Simon Watkins, Erik Koppes, Richard Haas, Jerry Vockley, Lina Ghaloul-Gonzalez, Paige Heiman, Al-Walid Mohsen, Anuradha Karunanidhi, Claudette St Croix, Simon Watkins, Erik Koppes, Richard Haas, Jerry Vockley, Lina Ghaloul-Gonzalez
Abstract
Transport and Golgi Organization protein 2 Homolog (TANGO2)-related disease is an autosomal recessive disorder caused by mutations in the TANGO2 gene. Symptoms typically manifest in early childhood and include developmental delay, stress-induced episodic rhabdomyolysis, and cardiac arrhythmias, along with severe metabolic crises including hypoglycemia, lactic acidosis, and hyperammonemia. Severity varies among and within families. Previous studies have reported contradictory evidence of mitochondrial dysfunction. Since the clinical symptoms and metabolic abnormalities are suggestive of a broad dysfunction of mitochondrial energy metabolism, we undertook a broad examination of mitochondrial bioenergetics in TANGO2 deficient patients utilizing skin fibroblasts derived from three patients exhibiting TANGO2-related disease. Functional studies revealed that TANGO2 protein was present in mitochondrial extracts of control cells but not patient cells. Superoxide production was increased in patient cells, while oxygen consumption rate, particularly under stress, along with relative ATP levels and β-oxidation of oleate were reduced. Our findings suggest that mitochondrial function should be assessed and monitored in all patients with TANGO2 mutation as targeted treatment of the energy dysfunction could improve outcome in this condition.
Conflict of interest statement
The authors declare no competing interests.
© 2022. The Author(s).
Figures
References
- Jennions E, et al. TANGO2 deficiency as a cause of neurodevelopmental delay with indirect effects on mitochondrial energy metabolism. J. Inherit. Metab. Dis. 2019;42(5):898–908. doi: 10.1002/jimd.12149.
- Bérat C-M, et al. Clinical and biological characterization of 20 patients with TANGO2 deficiency indicates novel triggers of metabolic crises and no primary energetic defect. J. Inherit. Metab. Dis. 2021;44(2):415–425. doi: 10.1002/jimd.12314.
- Lalani SR, et al. Recurrent muscle weakness with rhabdomyolysis, metabolic crises, and cardiac arrhythmia due to bi-allelic TANGO2 mutations. Am. J. Hum. Genet. 2016;98(2):347–357. doi: 10.1016/j.ajhg.2015.12.008.
- Kremer LS, et al. Bi-allelic truncating mutations in TANGO2 cause infancy-onset recurrent metabolic crises with encephalocardiomyopathy. Am. J. Hum. Genet. 2016;98(2):358–362. doi: 10.1016/j.ajhg.2015.12.009.
- Dines JN, et al. TANGO2: Expanding the clinical phenotype and spectrum of pathogenic variants. Genet Med. 2019;21(3):601–607. doi: 10.1038/s41436-018-0137-y.
- Bard F, et al. Functional genomics reveals genes involved in protein secretion and Golgi organization. Nature. 2006;439(7076):604–607. doi: 10.1038/nature04377.
- Milev MP, et al. The phenotype associated with variants in TANGO2 may be explained by a dual role of the protein in ER-to-Golgi transport and at the mitochondria. J. Inherit. Metab. Dis. 2020;44(2):426–437. doi: 10.1002/jimd.12312.
- Mingirulli N, et al. Clinical presentation and proteomic signature of patients with TANGO2 mutations. J. Inherit. Metab. Dis. 2020;43(2):297–308. doi: 10.1002/jimd.12156.
- Maynard TM, et al. Mitochondrial localization and function of a subset of 22q11 deletion syndrome candidate genes. Mol. Cell Neurosci. 2008;39(3):439–451. doi: 10.1016/j.mcn.2008.07.027.
- Seminotti B, et al. Mitochondrial energetics is impaired in very long-chain acyl-CoA dehydrogenase deficiency and can be rescued by treatment with mitochondria-targeted electron scavengers. Hum. Mol. Genet. 2019;28(6):928–941. doi: 10.1093/hmg/ddy403.
- de Moura MB, et al. Overexpression of mitochondrial sirtuins alters glycolysis and mitochondrial function in HEK293 cells. PLoS ONE. 2014;9(8):e106028. doi: 10.1371/journal.pone.0106028.
- Goetzman ES, et al. Long-chain acyl-CoA dehydrogenase deficiency as a cause of pulmonary surfactant dysfunction. J. Biol. Chem. 2014;289(15):10668–10679. doi: 10.1074/jbc.M113.540260.
- Schiff M, et al. Molecular and cellular pathology of very-long-chain acyl-CoA dehydrogenase deficiency. Mol. Genet. Metab. 2013;109(1):21–27. doi: 10.1016/j.ymgme.2013.02.002.
- Veeresh P, et al. Endoplasmic reticulum-mitochondria crosstalk: From junction to function across neurological disorders. Ann. N. Y. Acad. Sci. 2019;1457(1):41–60. doi: 10.1111/nyas.14212.
- Xie X, et al. In mitochondria ß-actin regulates mtDNA transcription and is required for mitochondrial quality control. iScience. 2018;3:226–237. doi: 10.1016/j.isci.2018.04.021.
- Xie X, et al. Mitochondria-localized beta-actin is essential for priming innate antiviral immune signaling by regulating IRF3 protein stability. Cell Mol. Immunol. 2019;16(10):837–840. doi: 10.1038/s41423-019-0269-2.
- Nsiah-Sefaa A, McKenzie M. Combined defects in oxidative phosphorylation and fatty acid β-oxidation in mitochondrial disease. Biosci. Rep. 2016;36(2):e00313. doi: 10.1042/BSR20150295.
- Wang Y, et al. Mitochondrial fatty acid oxidation and the electron transport chain comprise a multifunctional mitochondrial protein complex. J. Biol. Chem. 2019;294(33):12380–12391. doi: 10.1074/jbc.RA119.008680.
- Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science. 2012;337(6098):1062–1065. doi: 10.1126/science.1219855.
- Yu T, Wang L, Yoon Y. Morphological control of mitochondrial bioenergetics. Front. Biosci. (Landmark Ed.) 2015;20:229–246. doi: 10.2741/4306.
- Filadi R, Theurey P, Pizzo P. The endoplasmic reticulum-mitochondria coupling in health and disease: Molecules, functions and significance. Cell Calcium. 2017;62:1–15. doi: 10.1016/j.ceca.2017.01.003.
- Basso V, Marchesan E, Ziviani E. A trio has turned into a quartet: DJ-1 interacts with the IP3R-Grp75-VDAC complex to control ER-mitochondria interaction. Cell Calcium. 2020;87:102186. doi: 10.1016/j.ceca.2020.102186.
- Belkacemi A, et al. IP(3) receptor-dependent cytoplasmic Ca(2+) signals are tightly controlled by Cavβ3. Cell Rep. 2018;22(5):1339–1349. doi: 10.1016/j.celrep.2018.01.010.
Source: PubMed